190 related articles for article (PubMed ID: 38066651)
1. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
Horie Y; Yasuoka Y; Adachi T
Orphanet J Rare Dis; 2023 Dec; 18(1):384. PubMed ID: 38066651
[TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B; Bonkovsky HL; Lim JK; Balwani M
Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
[TBL] [Abstract][Full Text] [Related]
3. Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
J Intern Med; 2022 Jun; 291(6):824-836. PubMed ID: 35112415
[TBL] [Abstract][Full Text] [Related]
4. Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
Lissing M; Vassiliou D; Floderus Y; Harper P; Yan J; Hagström H; Sardh E; Wahlin S
J Inherit Metab Dis; 2023 Mar; 46(2):286-299. PubMed ID: 36546345
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of Japanese patients with acute hepatic porphyria.
Horie Y; Yasuoka Y; Adachi T
JIMD Rep; 2023 Jan; 64(1):71-78. PubMed ID: 36636592
[TBL] [Abstract][Full Text] [Related]
6. Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.
Wang B; Ventura P; Takase KI; Thapar M; Cassiman D; Kubisch I; Liu S; Sweetser MT; Balwani M
Orphanet J Rare Dis; 2022 Aug; 17(1):327. PubMed ID: 36028858
[TBL] [Abstract][Full Text] [Related]
7. Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.
Marcacci M; Ricci A; Cuoghi C; Marchini S; Pietrangelo A; Ventura P
Orphanet J Rare Dis; 2022 Apr; 17(1):160. PubMed ID: 35392955
[TBL] [Abstract][Full Text] [Related]
8. Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts.
Wheeden K; Lyon Howe D; Burrell S; Gill L; Chamberlayne J; Williams ER; Simon A; Ko JJ; Mora J; Wells T; Evans C; Paulich M; Meninger S; Lombardelli S
Adv Ther; 2022 Sep; 39(9):4330-4345. PubMed ID: 35907153
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminolevulinate dehydratase porphyria: Update on hepatic 5-aminolevulinic acid synthase induction and long-term response to hemin.
Lahiji AP; Anderson KE; Chan A; Simon A; Desnick RJ; Ramanujam VMS
Mol Genet Metab; 2020 Dec; 131(4):418-423. PubMed ID: 33199206
[TBL] [Abstract][Full Text] [Related]
10. Acute hepatic porphyria and cancer risk: a nationwide cohort study.
Baravelli CM; Sandberg S; Aarsand AK; Nilsen RM; Tollånes MC
J Intern Med; 2017 Sep; 282(3):229-240. PubMed ID: 28730628
[TBL] [Abstract][Full Text] [Related]
11. EXPLORE B: A prospective, long-term natural history study of patients with acute hepatic porphyria with chronic symptoms.
Cassiman D; Kauppinen R; Monroy S; Lee MJ; Bonkovsky HL; Thapar M; Guillén-Navarro E; Minder AE; Hale C; Sweetser MT; Ivanova A
J Inherit Metab Dis; 2022 Nov; 45(6):1163-1174. PubMed ID: 36069414
[TBL] [Abstract][Full Text] [Related]
12. The clinical importance of early acute hepatic porphyria diagnosis: a national cohort.
Edel Y; Mamet R; Cohen S; Shepshelovich D; Levi A; Sagy I
Intern Emerg Med; 2021 Jan; 16(1):133-139. PubMed ID: 32372331
[TBL] [Abstract][Full Text] [Related]
13. Neurology of the acute hepatic porphyrias.
Oliveira Santos M; Leal Rato M
J Neurol Sci; 2021 Sep; 428():117605. PubMed ID: 34375916
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword.
Peoc'h K; Manceau H; Karim Z; Wahlin S; Gouya L; Puy H; Deybach JC
Mol Genet Metab; 2019 Nov; 128(3):236-241. PubMed ID: 30413387
[TBL] [Abstract][Full Text] [Related]
15. Expert consensus statement on acute hepatic porphyria in Belgium.
Gilles A; Vermeersch S; Vermeersch P; Wolff F; Cotton F; Tilleux S; Cassiman D
Acta Clin Belg; 2022 Aug; 77(4):735-741. PubMed ID: 34369323
[TBL] [Abstract][Full Text] [Related]
16. Givosiran: A Review in Acute Hepatic Porphyria.
Syed YY
Drugs; 2021 May; 81(7):841-848. PubMed ID: 33871817
[TBL] [Abstract][Full Text] [Related]
17. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.
Bonkovsky HL; Maddukuri VC; Yazici C; Anderson KE; Bissell DM; Bloomer JR; Phillips JD; Naik H; Peter I; Baillargeon G; Bossi K; Gandolfo L; Light C; Bishop D; Desnick RJ
Am J Med; 2014 Dec; 127(12):1233-41. PubMed ID: 25016127
[TBL] [Abstract][Full Text] [Related]
18. Case-based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management.
Balwani M; Keel S; Meissner P; Sonderup M; Stein P; Yasuda M
Liver Int; 2024 Apr; ():. PubMed ID: 38618923
[TBL] [Abstract][Full Text] [Related]
19. PICO questions and DELPHI methodology for improving the management of patients with acute hepatic porphyria.
Riera-Mestre A; García Morillo JS; Castelbón Fernández J; Hernández-Contreras ME; Aguilera Peiró P; Jacob J; Martínez Valle F; Guillén-Navarro E; Morales-Conejo M
Rev Clin Esp (Barc); 2024 May; 224(5):272-280. PubMed ID: 38642893
[TBL] [Abstract][Full Text] [Related]
20. Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study.
Gill L; Burrell S; Chamberlayne J; Lombardelli S; Mora J; Mason N; Schurer M; Merkel M; Meninger S; Ko JJ
Orphanet J Rare Dis; 2021 Apr; 16(1):187. PubMed ID: 33902669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
